| Authors: |
Johnson AE; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Tate M; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Filippovych M; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Bromberg DJ; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Kiriazova T; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Madden LM; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Dvoriak S; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA., Altice FL; Ann E. Johnson, PhD, is an MD Candidate, Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA.; Mary Tate, BA, MPH, is a PhD Student in the Department of Social Anthropology, University of Cambridge, Cambridge, United Kingdom, and Yale School of Public Health, New Haven, Connecticut, USA.; Myroslava Filippovych, MPH, is a Research Associate at the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Daniel J. Bromberg, PhD, is Group Lead, Substance Use and Global Health, at the Heidelberg Institute of Global Health, Heidelberg University, Heidelberg, Germany, and Yale School of Public Health, New Haven, Connecticut, USA.; Tetiana Kiriazova, PhD, is the Director of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Lynn M. Madden, PhD, is an Assistant Professor Adjunct at the Yale School of Medicine, and President/CEO of the APT Foundation, New Haven, Connecticut, USA.; Sergii Dvoriak, MD, PhD, is Co-founder of the Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.; Frederick L. Altice, MD, is a Professor of Medicine and Epidemiology at the Yale School of Medicine and Yale School of Public Health, New Haven, Connecticut, USA. |
